Tyra Biosciences (TYRA) Current Leases (2020 - 2026)

Tyra Biosciences (TYRA) has 7 years of Current Leases data on file, last reported at $488000.0 in Q1 2026.

• Quarterly Current Leases rose 14.55% year-over-year to $488000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $488000.0 (up 14.55% YoY) and the FY2025 annual result came in at $472000.0, up 14.56% from the prior year.
• Current Leases improved to $488000.0 in Q1 2026, from $472000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $488000.0 in Q1 2026 to a low of $119000.0 in Q1 2022.
• A 5-year average of $298294.1 and a median of $370000.0 in 2024 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2022 — Current Leases plunged 30.69% — and 2024, when it soared 168.92%.
• Tracing TYRA's Current Leases over 5 years: stood at $140000.0 in 2022, then surged by 100.0% to $280000.0 in 2023, then surged by 47.14% to $412000.0 in 2024, then advanced by 14.56% to $472000.0 in 2025, then rose by 3.39% to $488000.0 in 2026.
• The last three Current Leases figures came in at $488000.0 (Q1 2026), $472000.0 (Q4 2025), and $456000.0 (Q3 2025), per Business Quant data.